메뉴 건너뛰기




Volumn 902, Issue , 2012, Pages 47-54

Liquid chromatography-mass spectrometric determination of losartan and its active metabolite on dried blood spots

Author keywords

Dried blood spots (DBS); LC MS MS; Losartan (LOS); Losartan carboxylic acid (LCA); Stability; Validation

Indexed keywords

ACCEPTABLE LIMIT; ACTIVE METABOLITES; ANALYTES; AQUEOUS AMMONIUM; AQUEOUS METHANOL; BIOANALYTICAL; DRIED BLOOD SPOTS; ELUENTS; INTERNAL STANDARDS; ION TRANSITION; IRBESARTAN; LC-MS/MS; LINEAR RANGE; LOSARTAN; LOWER LIMITS; MATRIX EFFECTS; MOBILE PHASE; NEGATIVE POLARITY; REGULATORY GUIDELINES; SIMULTANEOUS DETERMINATIONS; STOCK SOLUTIONS; TANDEM MASS SPECTROMETRIC DETECTION; VALIDATION; VALIDATION PARAMETERS; WHOLE BLOOD;

EID: 84864099935     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2012.06.013     Document Type: Article
Times cited : (18)

References (63)
  • 62
    • 84864093810 scopus 로고    scopus 로고
    • Guideline on validation of bioanalytical methods; EMEA/CHMP/EWP/192217/2009, European Medicines Agency
    • Guideline on validation of bioanalytical methods; EMEA/CHMP/EWP/192217/2009, European Medicines Agency, 2009.
    • (2009)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.